Transdermal testosterone in women aged 35-55 years with SSRI- or SNRI-induced female sexual dysfunction

Trial Profile

Transdermal testosterone in women aged 35-55 years with SSRI- or SNRI-induced female sexual dysfunction

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2013

At a glance

  • Drugs Testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2013 New trial record
    • 12 Oct 2013 Primary endpoint 'Sexual-functioning' has not been met.
    • 12 Oct 2013 Results presented at the 24th Annual Meeting of the North American Menopause Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top